Aldeyra Therapeutics (ALDX) Earnings Date, Estimates & Call Transcripts → Chances are you know the firms on this list (From WealthPress) (Ad) Free ALDX Stock Alerts $3.87 +0.01 (+0.26%) (As of 05:45 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 1EstimatedActual EPS (May. 2) -$0.14 Missed By -$0.06 Consensus EPS (May. 2) -$0.08 Get Aldeyra Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ALDX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueALDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ALDX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad WealthPressOptions expert shares his top option strategy for freeA 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.Check it out, simply follow this link here. Aldeyra Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.15)$0.02($0.07)Q2 20242($0.15)($0.14)($0.15)Q3 20242($0.19)($0.17)($0.18)Q4 20242($0.18)$1.42$0.62FY 20248($0.67)$1.13$0.23ALDX Earnings Date and InformationAldeyra Therapeutics last released its quarterly earnings data on May 2nd, 2024. The biotechnology company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.06. Aldeyra Therapeutics has generated ($0.51) earnings per share over the last year (($0.51) diluted earnings per share). Earnings for Aldeyra Therapeutics are expected to decrease in the coming year, from ($0.23) to ($0.43) per share. Aldeyra Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.Read More Aldeyra Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/1/2024(Estimated)------- 5/2/2024Q1 2024($0.08)($0.14)($0.06)($0.14)--3/7/2024Q4 2023($0.21)($0.08)+$0.13($0.08)--11/3/2023Q3 2023-($0.14)($0.14)($0.14)--8/3/2023Q2 2023($0.31)($0.15)+$0.16($0.15)--5/4/2023Q1 2023($0.30)($0.27)+$0.03($0.27)--3/9/2023Q4 2022($0.34)($0.22)+$0.12($0.22)-- Get the Latest News and Ratings for ALDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aldeyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022($0.34)($0.25)+$0.09($0.25)--8/5/2022Q2 2022($0.32)($0.30)+$0.02($0.30)--5/5/2022Q1 2022($0.31)($0.29)+$0.02($0.29)-- 3/17/2022Q4 2021($0.31)($0.27)+$0.04($0.27)-- 10/27/2021Q3 2021($0.26)($0.27)($0.01)($0.27)-- 8/4/2021Q2 2021($0.24)($0.28)($0.04)($0.28)-- 5/5/2021Q1 2021($0.29)($0.25)+$0.04($0.25)-- 3/10/2021Q4($0.28)($0.30)($0.02)($0.35)-- 11/10/2020Q3 2020($0.27)($0.23)+$0.04($0.23)-- 8/6/2020Q2 2020($0.34)($0.25)+$0.09($0.25)-- 5/7/2020Q1 2020($0.48)($0.34)+$0.14($0.34)-- 3/12/2020Q4 2019($0.68)($0.47)+$0.21($0.47)-- 11/7/2019Q3($0.55)($0.69)($0.14)($0.69)-- 8/8/2019Q2 2019($0.51)($0.4939)+$0.0161($0.49)-- Aldeyra Therapeutics Earnings - Frequently Asked Questions When is Aldeyra Therapeutics's earnings date? Aldeyra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on ALDX's earnings history. Did Aldeyra Therapeutics beat their earnings estimates last quarter? In the previous quarter, Aldeyra Therapeutics (NASDAQ:ALDX) missed the analysts' consensus estimate of ($0.08) by $0.06 with a reported earnings per share (EPS) of ($0.14). Learn more on analysts' earnings estimate vs. ALDX's actual earnings. How much profit does Aldeyra Therapeutics generate each year? Aldeyra Therapeutics (NASDAQ:ALDX) has a recorded net income of -$37.54 million. ALDX has generated -$0.51 earnings per share over the last four quarters. What is Aldeyra Therapeutics's EPS forecast for next year? Aldeyra Therapeutics's earnings are expected to decrease from ($0.23) per share to ($0.43) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Nature's Sunshine Products Earnings Verrica Pharmaceuticals Earnings Verastem Earnings NextCure Earnings CureVac Earnings Tyra Biosciences Earnings Gyre Therapeutics Earnings Arcutis Biotherapeutics Earnings Disc Medicine Earnings ARS Pharmaceuticals Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:ALDX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aldeyra Therapeutics, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aldeyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.